Post

Exscientia receives approval to begin advanced solid tumour therapy trial

The trail will assess EXS-21546 along with anti-PD-1 therapy in relapsed or refractory RCC and NSCLC patients.

Cancer Research UK and Stitch to pilot app for patients in trials

Trialmap helps participants to view data on the trial and receive reminders for appointments.

A third of all schizophrenia cases go undiagnosed

Only around two in three individuals with schizophrenia are diagnosed by a physician, likely due to misdiagnosis of the condition.

Anticoagulant unbeneficial for Covid-19 University of Cambridge trial finds

The blood thinning therapy caused major bleeding that led to the discontinuation of the treatment in these patients.

Almirall to take part in FACILITATE project to enable trial data usage

The project is based on a technology platform and comprises 27 partners from 17 EU and non-EU Member States.